Seres Therapeutics, Inc.: meeting of 26 Sep 2024

Votes reported on Form N-PX, item by item

85 Form N-PX filers reported votes at the Seres Therapeutics, Inc. meeting of 26 Sep 2024. Their records fall into 4 items below, in ballot order: management items first, then proposals from security holders. Each bar shows how the reporting filers split; it is not the result of the meeting.

foragainstabstain, withhold or otheramber tick: the portion cast against management

Items

SECTION 14A SAY-ON-PAY VOTESIssuer

Advisory vote on executive pay (say-on-pay)

1 vote records from 1 filers. 0 of the 1 filers that marked the item either way voted against management.

100.0% for0.0% against0.0% against management1 filers100.0% for0.0% against0.0% against management20,968 reported shares

SECTION 14A SAY-ON-PAY VOTESIssuer

Advisory vote on pay tied to a merger or sale

99 vote records from 83 filers. 2 of the 77 filers that marked the item either way voted against management. 6 filers reported this item without a management mark.

91.6% for1.2% against7.2% other2.6% against management83 filers100.0% for0.0% against0.0% against management34,015,779 reported shares

EXTRAORDINARY TRANSACTIONSIssuer

EXTRAORDINARY TRANSACTIONS: management items

Management items in this category are shown together; filers word and number them differently.

28 vote records from 19 filers. 0 of the 19 filers that marked the item either way voted against management.

100.0% for0.0% against0.0% against management19 filers100.0% for0.0% against0.0% against management12,828,756 reported shares, counted once per item in this group

CORPORATE GOVERNANCEIssuer

CORPORATE GOVERNANCE: management items

Management items in this category are shown together; filers word and number them differently.

28 vote records from 19 filers. 1 of the 19 filers that marked the item either way voted against management.

94.7% for5.3% against5.3% against management19 filers92.5% for7.5% against7.5% against management12,828,756 reported shares, counted once per item in this group

How the largest families voted

Family	2. Merger pay
Vanguard	For
BlackRock and iShares	For
Fidelity	For
State Street and SPDR	For
Invesco	For
Charles Schwab	For
Morgan Stanley, Eaton Vance and Calvert	For
Goldman Sachs	For
PGIM and Prudential	For
Northern Trust and FlexShares	For
T. Rowe Price	For
Russell Investments	For
Victory Capital	For
Guggenheim and Rydex	For
BNY Mellon	For
Federated Hermes	For
Allspring	For
Neuberger Berman	For
Natixis and Loomis Sayles	For

* against management. A family's position is the way most of its reported shares were voted across its filers; "split" means no single position led. "No report" means none of the family's filers listed the item.

Questions

How did large funds vote at the Seres Therapeutics, Inc. meeting?

85 Form N-PX filers reported votes at the meeting of 26 Sep 2024. On say-on-pay, 0 of 1 voted against management (0.0%). The family table lists each of the largest families item by item.

Is this the meeting result?

No. These are the votes of funds and managers that file Form N-PX, counted by filer and by the shares they reported. The certified result, which includes every shareholder, is reported by Seres Therapeutics, Inc. on Form 8-K.

Why are director elections shown as counts only?

Director records name the nominee. This site does not publish pages or rows about individuals, so for director elections it keeps the number of nominees and the split of votes and discards the wording.

Every meeting on file for Seres Therapeutics, Inc.

Provenance: SEC EDGAR, Form N-PX and N-PX/A filings listing Seres Therapeutics, Inc. with a meeting date within three days of 26 Sep 2024. Proposal titles are the most common wording among filers and are replaced by the SEC category where a wording could name a person. Not verified by the SEC. Filings read through 23 Sep 2026.